This page is part of the Potential Drug-Drug Interaction (PDDI) Clinical Decision Support (CDS) (FHIR IG) (v1.0.0: STU 1) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
| Official URL: http://hl7.org/fhir/uv/pddi/ValueSet/valueset-nabumetone | Version: 1.0.0 | ||||
| Standards status: Informative | Computable Name: Valueset_nabumetone | ||||
Copyright/Legal: (copyright expectations unknown) |
|||||
ValueSet containing drug identifiers for nabumetone.
References
http://www.nlm.nih.gov/research/umls/rxnorm version Not Stated (use latest from terminology server)| Code | Display |
| 31448 | nabumetone |
| 105953 | nabumetone 100 MG/ML Oral Suspension |
| 311892 | nabumetone 500 MG Oral Tablet |
| 311893 | nabumetone 750 MG Oral Tablet |
| 392641 | nabumetone 2.5 MG/ML Oral Solution |
| 335255 | nabumetone 100 MG/ML |
| 343093 | nabumetone 750 MG |
| 343109 | nabumetone 500 MG |
| 393527 | nabumetone 2.5 MG/ML |
| 372976 | nabumetone Oral Suspension |
| 378684 | nabumetone Oral Tablet |
| 393528 | nabumetone Oral Solution |
| 1158378 | nabumetone Oral Liquid Product |
| 1158379 | nabumetone Oral Product |
| 1158380 | nabumetone Pill |
Expansion from tx.fhir.org based on codesystem RxNorm version 03022026
This value set contains 15 concepts